APH vs XTNT · P/E 40, rev $23.09B vs rev $133.9M
Amphenol Corporation (APH) versus Xtant Medical Holdings Inc (XTNT) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Xtant Medical Holdings Inc (XTNT) is a medical devices company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported XTNT revenue for 2025-12-31 was $133.9M. Net income was $5.0M. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. XTNT currently screens at market cap $91.0M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. XTNT currently screens at market cap $91.0M.
Not investment advice. Open the APH and XTNT stock pages for the full models.
Not investment advice.